[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-001", "question": "A 58-year-old woman with hypertrophic cardiomyopathy presents with progressive dyspnea and New York Heart Association class III symptoms despite maximum tolerated doses of metoprolol and verapamil. Echocardiography reveals a resting left ventricular outflow tract (LVOT) gradient of 85 mmHg, septal thickness of 22 mm, and systolic anterior motion of the mitral valve with moderate mitral regurgitation. She has no coronary artery disease on angiography. The septal perforator anatomy is suitable for intervention. Which of the following findings would most strongly favor surgical myectomy over alcohol septal ablation in this patient?", "options": ["Concomitant intrinsic mitral valve disease requiring repair", "Patient preference for less invasive procedure", "Presence of atrial fibrillation requiring maze procedure consideration", "Septal thickness greater than 20 mm", "Age greater than 55 years"], "answer": "A", "answer_index": 0, "explanation": "Surgical myectomy is preferred over alcohol septal ablation when concomitant cardiac pathology requiring surgical correction exists, such as intrinsic mitral valve disease (leaflet abnormalities, chordal pathology) needing repair or replacement. While septal thickness >30mm and unsuitable coronary anatomy favor surgery, 22mm thickness alone does not preclude ablation. Atrial fibrillation can be addressed with catheter ablation. Age and patient preference, while considerations, are not absolute indications for one approach over another.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The answer is A.  \n\nSurgical myectomy is preferred over alcohol septal ablation when there is concomitant intrinsic mitral valve disease requiring repair (such as primary structural mitral valve abnormalities), because surgery allows for direct inspection and repair of the mitral valve.  \nWhile other factors (age, septal thickness, atrial fibrillation) may influence decision-making, the presence of intrinsic mitral valve pathology is a strong indication for surgery rather than ablation.  \n\nThe answer is A"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-002", "question": "A 6-year-old boy presents with recurrent episodes of weakness and dark urine following viral illnesses. Laboratory studies during an acute episode show: serum creatine kinase 45,000 U/L, myoglobinuria, and non-ketotic hypoglycemia with inappropriately low free fatty acids. Acylcarnitine profile shows elevated C14:1 and C14:2 species. Genetic testing confirms compound heterozygous mutations in ACADVL. Which of the following dietary modifications is most critical for preventing future metabolic crises?", "options": ["Strict avoidance of medium-chain triglycerides", "Supplementation with odd-chain fatty acids", "Restriction of long-chain fatty acids with medium-chain triglyceride supplementation", "High-protein diet with branched-chain amino acid supplementation", "Carnitine supplementation with unrestricted fat intake"], "answer": "C", "answer_index": 2, "explanation": "ACADVL mutations cause very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency, a disorder of long-chain fatty acid oxidation. Management requires restriction of long-chain fatty acids (which cannot be metabolized) and supplementation with medium-chain triglycerides (MCTs), which bypass the defective enzyme and provide an alternative energy source. MCT avoidance would be harmful. Carnitine supplementation alone without dietary modification is insufficient, and high-protein diets do not address the underlying metabolic defect.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has very long-chain acyl-CoA dehydrogenase deficiency (VLCADD), based on the ACADVL mutations and the acylcarnitine profile showing elevated C14:1 and C14:2 species.  \nIn VLCADD, long-chain fatty acid oxidation is impaired, leading to energy deficiency and toxic metabolite accumulation during fasting or stress.  \nManagement involves avoiding long-chain triglycerides (LCT) and providing medium-chain triglycerides (MCT) as an alternative energy source because MCT are metabolized independently of VLCAD.  \n\nOption C correctly describes this approach: restriction of long-chain fatty acids with medium-chain triglyceride supplementation.  \n\nThe answer is C"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-003", "question": "A 34-year-old woman with systemic lupus erythematosus on hydroxychloroquine and mycophenolate presents with acute onset severe headache, confusion, and seizures. Blood pressure is 168/102 mmHg. MRI brain shows bilateral posterior white matter T2/FLAIR hyperintensities without restricted diffusion. Lumbar puncture shows normal opening pressure, 8 WBC/μL (lymphocyte predominant), protein 52 mg/dL, and negative cultures. Anti-ribosomal P antibodies are positive. Which additional finding would most strongly suggest neuropsychiatric lupus rather than posterior reversible encephalopathy syndrome (PRES)?", "options": ["Presence of anti-dsDNA antibodies at high titer", "Low complement C3 and C4 levels", "Elevated CSF IgG index with oligoclonal bands", "Resolution of MRI findings with blood pressure control", "Concurrent lupus nephritis flare"], "answer": "C", "answer_index": 2, "explanation": "Elevated CSF IgG index with oligoclonal bands indicates intrathecal immunoglobulin synthesis, strongly supporting CNS inflammation from neuropsychiatric lupus (NPSLE) rather than PRES, which is a vasogenic edema syndrome without primary CNS inflammation. Anti-dsDNA antibodies and low complements indicate systemic lupus activity but don't differentiate CNS involvement. Resolution with BP control would actually favor PRES. Concurrent nephritis indicates systemic activity but doesn't confirm CNS-specific disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The key distinction is between neuropsychiatric SLE (NPSLE) and PRES, which can both occur in lupus.  \nPRES is typically reversible with blood pressure control and is not directly inflammatory, while NPSLE often shows inflammatory CSF and immunological activity.  \n\n- **A and B** (anti-dsDNA, low complement) indicate systemic lupus activity but can occur in both PRES (due to renal flare) and NPSLE.  \n- **C** (elevated CSF IgG index with oligoclonal bands) suggests intrathecal inflammation, which is more specific for NPSLE than PRES.  \n- **D** (resolution with BP control) favors PRES.  \n- **E** (concurrent lupus nephritis flare) can trigger PRES and is not specific.  \n\nThe most direct evidence for NPSLE over PRES is **inflammatory CSF with IgG index/oligoclonal bands**, pointing to immune-mediated CNS involvement.  \n\nThe answer is (C)"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-004", "question": "A 52-year-old man with type 2 diabetes presents for evaluation of recurrent hypoglycemia occurring 3-4 hours postprandially. He underwent Roux-en-Y gastric bypass 2 years ago with 45 kg weight loss. During a symptomatic episode, laboratory studies show: glucose 38 mg/dL, insulin 45 μU/mL (elevated), C-peptide 8.2 ng/mL (elevated), proinsulin 22 pmol/L (elevated), and negative sulfonylurea screen. Calcium-stimulated angiography localizes insulin secretion to the body and tail of the pancreas. Which of the following is the most appropriate next step in management?", "options": ["Distal pancreatectomy", "Diazoxide therapy", "Octreotide therapy", "Dietary modification with acarbose", "Enucleation of insulinoma"], "answer": "D", "answer_index": 3, "explanation": "This presentation is classic for post-gastric bypass hyperinsulinemic hypoglycemia (nesidioblastosis/non-insulinoma pancreatogenous hypoglycemia syndrome). Unlike insulinoma, this involves diffuse islet cell hyperfunction. First-line management is dietary modification (low glycemic index, frequent small meals) combined with acarbose to slow carbohydrate absorption and blunt the exaggerated incretin response. Distal pancreatectomy is reserved for refractory cases. The diffuse localization on angiography and post-bypass context argue against focal insulinoma requiring enucleation.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The patient has post-bariatric surgery hyperinsulinemic hypoglycemia (often called post-gastric bypass hypoglycemia or nesidioblastosis), not a solitary insulinoma.  \nCalcium-stimulated angiography shows diffuse insulin secretion from the body and tail, making enucleation or distal pancreatectomy less appropriate as first-line therapy.  \nInitial management is usually dietary modification (frequent small meals, low carbohydrate) and possibly acarbose to slow carbohydrate absorption.  \nIf medical management fails, distal pancreatectomy may be considered, but it is not the most appropriate next step initially.  \n\nThe answer is D"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-005", "question": "A 3-week-old male infant presents with poor feeding, lethargy, and hypotonia. He was born at term following an uncomplicated pregnancy. Physical examination reveals hepatomegaly, hypotonia, and macroglossia. Echocardiography shows severe biventricular hypertrophy with a left ventricular ejection fraction of 25%. Laboratory studies show elevated creatine kinase and AST. Urine organic acids are normal. Enzyme assay on dried blood spot shows markedly reduced acid alpha-glucosidase activity. Genetic testing confirms two pathogenic variants in GAA. Which of the following factors is most predictive of poor response to enzyme replacement therapy?", "options": ["Presence of cardiomyopathy at diagnosis", "Cross-reactive immunologic material (CRIM) negative status", "Age at diagnosis less than 1 month", "Elevated creatine kinase level", "Presence of macroglossia"], "answer": "B", "answer_index": 1, "explanation": "In infantile-onset Pompe disease, CRIM-negative status (complete absence of endogenous GAA protein) is the strongest predictor of poor response to enzyme replacement therapy (ERT) due to development of high-sustained antibody titers against the recombinant enzyme, which neutralize therapeutic effect. CRIM-negative patients require immune tolerance induction protocols. While early cardiomyopathy and young age at diagnosis indicate severe disease, CRIM-positive patients with these features can still respond well to ERT. Elevated CK and macroglossia are disease markers but not predictive of treatment response.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The clinical presentation and lab findings are classic for infantile-onset Pompe disease (glycogen storage disease type II), caused by deficiency of acid alpha-glucosidase (GAA).  \nEnzyme replacement therapy (ERT) with alglucosidase alfa is the standard treatment.  \nA key factor influencing response to ERT is whether the patient produces any endogenous enzyme protein.  \nCross-reactive immunologic material (CRIM) negative status means the patient has no residual enzyme protein, leading to a high likelihood of developing high-titer antibodies against the infused enzyme, which reduces efficacy and worsens outcomes.  \nCRIM-negative status is a well-established predictor of poor response to ERT in infantile Pompe disease.  \n\nThe answer is B"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-006", "question": "A 67-year-old man with ischemic cardiomyopathy (LVEF 28%) and an implantable cardioverter-defibrillator presents after receiving three appropriate shocks for ventricular tachycardia over 24 hours despite amiodarone 400 mg daily. He is hemodynamically stable with blood pressure 102/68 mmHg. ECG shows sinus rhythm at 72 bpm with QTc 485 ms. Electrolytes and thyroid function are normal. Device interrogation confirms monomorphic VT at 188 bpm terminated by ATP and shocks. Which of the following is the most appropriate next step?", "options": ["Increase amiodarone to 600 mg daily", "Add mexiletine 200 mg three times daily", "Urgent catheter ablation of ventricular tachycardia", "Initiate dofetilide after appropriate QTc assessment", "Add ranolazine 500 mg twice daily"], "answer": "C", "answer_index": 2, "explanation": "This patient has electrical storm (≥3 sustained VT/VF episodes in 24 hours) refractory to amiodarone, which is a class I indication for urgent catheter ablation per current guidelines. Increasing amiodarone risks toxicity and QT prolongation. Adding mexiletine is reasonable for adjunctive therapy but does not address the substrate. Dofetilide is contraindicated with QTc >440ms in men and in the acute setting. Ranolazine has limited evidence for VT suppression. Catheter ablation targeting the VT substrate offers the best chance of preventing recurrent episodes.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has ischemic cardiomyopathy with recurrent VT despite amiodarone therapy, and is already on a typical maintenance dose.  \nIncreasing amiodarone further raises toxicity risk with limited additional antiarrhythmic benefit.  \nAdding mexiletine or ranolazine could be considered but is less definitive for controlling recurrent shocks.  \nDofetilide carries proarrhythmia risk and is not first-line in this setting.  \nCatheter ablation is recommended for recurrent VT despite antiarrhythmic drugs, especially when ICD shocks are occurring, to reduce VT burden and shocks.  \n\nThe answer is C"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-007", "question": "A 14-year-old girl presents with 6 months of progressive proximal muscle weakness, heliotrope rash, and Gottron papules. She has difficulty climbing stairs and raising her arms. Laboratory studies show CK 4,200 U/L and positive anti-MDA5 antibodies. Chest CT reveals subtle ground-glass opacities in bilateral lower lobes. Pulmonary function tests show FVC 72% predicted and DLCO 58% predicted. Muscle biopsy shows perifascicular atrophy. Which of the following findings most significantly increases her risk of rapidly progressive interstitial lung disease?", "options": ["Elevated serum ferritin level", "Presence of mechanic's hands", "Positive anti-Jo-1 antibodies", "Calcinosis cutis on examination", "Elevated aldolase level"], "answer": "A", "answer_index": 0, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is associated with rapidly progressive interstitial lung disease (RP-ILD), which can be fatal. Elevated serum ferritin is a biomarker strongly associated with RP-ILD severity and poor prognosis in anti-MDA5 positive patients, reflecting macrophage activation. Anti-Jo-1 is associated with ILD but typically a more chronic course. Mechanic's hands are associated with antisynthetase syndrome. Calcinosis and elevated aldolase are features of juvenile DM but not specific predictors of RP-ILD in anti-MDA5 disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has juvenile dermatomyositis with anti-MDA5 antibodies, which is strongly associated with rapidly progressive interstitial lung disease (RP-ILD).  \nAmong the options, **elevated serum ferritin** is a recognized biomarker for severe disease and increased mortality risk in MDA5-positive dermatomyositis, especially with RP-ILD.  \n\nThe answer is A"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-008", "question": "A 42-year-old woman presents to the emergency department with acute chest pain and dyspnea. She has a history of antiphospholipid syndrome with prior deep vein thrombosis, currently on warfarin with INR 2.8. ECG shows sinus tachycardia with new right bundle branch block. CT pulmonary angiography reveals bilateral pulmonary emboli with right ventricular dilation. Troponin I is 0.89 ng/mL. Blood pressure is 88/54 mmHg, heart rate 118 bpm. Despite 2 liters of crystalloid, blood pressure remains 84/52 mmHg. Which of the following is the most appropriate next step?", "options": ["Initiate unfractionated heparin infusion", "Administer systemic alteplase", "Perform catheter-directed thrombolysis", "Emergent surgical embolectomy", "Initiate norepinephrine and observe"], "answer": "B", "answer_index": 1, "explanation": "This patient has high-risk (massive) pulmonary embolism with hemodynamic instability (persistent hypotension despite fluid resuscitation) and RV dysfunction. Systemic thrombolysis with alteplase is the first-line treatment for hemodynamically unstable PE per guidelines, even in anticoagulated patients, as the mortality benefit outweighs bleeding risk. The therapeutic INR does not preclude thrombolysis in this life-threatening situation. Catheter-directed therapy or surgical embolectomy are alternatives if thrombolysis is contraindicated or fails. Simply adding vasopressors without addressing the obstruction is inadequate.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has a high-risk (massive) pulmonary embolism with hypotension (SBP <90 mmHg) that persists after fluid resuscitation, along with right ventricular dysfunction and elevated troponin. In a patient with high-risk PE and hemodynamic instability, systemic thrombolysis is the recommended first-line therapy unless contraindicated.  \n\nAlthough she is on warfarin with INR 2.8, this is therapeutic and not a major bleeding risk for thrombolysis in a life-threatening situation. Catheter-directed thrombolysis or surgical embolectomy are alternatives if thrombolysis is contraindicated or if the patient deteriorates, but systemic thrombolysis is the most appropriate immediate intervention here.  \n\nThe answer is B"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-009", "question": "A 28-year-old woman with Graves' disease treated with methimazole 30 mg daily for 8 weeks presents with fever (39.2°C), severe sore throat, and malaise for 2 days. Physical examination reveals pharyngeal erythema without exudate and no lymphadenopathy. Complete blood count shows WBC 1,200/μL with absolute neutrophil count 80/μL, hemoglobin 13.2 g/dL, and platelets 245,000/μL. Which of the following is the most appropriate immediate management?", "options": ["Discontinue methimazole and initiate propylthiouracil", "Discontinue methimazole, obtain blood cultures, and initiate broad-spectrum antibiotics with G-CSF", "Continue methimazole at reduced dose with close monitoring", "Discontinue methimazole and proceed with urgent thyroidectomy", "Discontinue methimazole and initiate lithium carbonate"], "answer": "B", "answer_index": 1, "explanation": "This patient has methimazole-induced agranulocytosis (ANC <500/μL), a rare but life-threatening complication occurring in 0.1-0.5% of patients, typically within the first 3 months. Management requires immediate discontinuation of the offending thionamide (cross-reactivity precludes switching to PTU), blood cultures, broad-spectrum antibiotics covering Pseudomonas given febrile neutropenia, and G-CSF to accelerate neutrophil recovery. Continuing or reducing methimazole is dangerous. Urgent thyroidectomy in an agranulocytic patient carries prohibitive infection risk. Alternative thyroid control can be achieved with beta-blockers, iodine, or lithium after stabilization.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient on methimazole presents with fever, severe sore throat, and profound neutropenia (absolute neutrophil count 80/μL), consistent with methimazole-induced agranulocytosis. This is a medical emergency due to the high risk of life-threatening infection. Immediate management includes stopping the offending drug, evaluating for infection (cultures), and starting empiric broad-spectrum antibiotics along with consideration of G-CSF to aid neutrophil recovery.  \n\nThe answer is B"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed127-010", "question": "A 9-year-old boy with a history of Kawasaki disease at age 2 (treated with IVIG and aspirin, with documented giant coronary artery aneurysms) presents for routine cardiology follow-up. He is asymptomatic and active without limitations. Current medications include aspirin 81 mg daily and clopidogrel 75 mg daily. Echocardiography shows a 9 mm right coronary artery aneurysm (z-score +12) and 7 mm left anterior descending aneurysm (z-score +9). Stress MRI perfusion shows no inducible ischemia. Which of the following additional interventions is most strongly recommended based on current guidelines?", "options": ["Addition of warfarin with target INR 2.0-3.0", "Discontinuation of clopidogrel given no ischemia", "Annual exercise stress testing only", "Coronary CT angiography every 5 years", "Restriction from all competitive sports"], "answer": "A", "answer_index": 0, "explanation": "Giant coronary artery aneurysms (z-score ≥10 or absolute diameter ≥8mm) represent the highest risk category in Kawasaki disease and require triple antithrombotic therapy: aspirin, a second antiplatelet agent (clopidogrel), AND systemic anticoagulation with warfarin (target INR 2.0-3.0) or LMWH per AHA guidelines. This is due to high thrombotic risk within aneurysms. The absence of current ischemia does not reduce thrombotic risk. These patients require activity restriction from contact/collision sports but the antithrombotic intensification is the most critical missing intervention.", "generator_model": "claude-opus-4-5-20251101", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "Based on current guidelines for Kawasaki disease with giant coronary artery aneurysms (≥8 mm or z-score ≥10), long-term anticoagulation in addition to antiplatelet therapy is recommended to reduce the risk of thrombosis, regardless of whether ischemia is present on testing.  \n\nThe patient has a giant aneurysm (9 mm, z-score +12) and is already on dual antiplatelet therapy (aspirin + clopidogrel). Guidelines (AHA 2017) suggest that for giant aneurysms, especially with additional risk factors or in males, warfarin (INR 2.0–2.5) or low-molecular-weight heparin should be added to low-dose aspirin.  \n\nThe other options are not the most strongly recommended:  \n- Discontinuing clopidogrel (B) would reduce antiplatelet protection, which is not advised.  \n- Annual exercise testing (C) is reasonable but not the most critical missing intervention.  \n- Coronary CT angiography (D) may be used but not necessarily every 5 years as a strong recommendation over anticoagulation.  \n- Sports restriction (E) is individualized; many guidelines allow low-static/low-dynamic sports if no ischemia, so not the most strongly recommended here.  \n\nThe answer is A"}]